Economizing comparative Poisson clinical trials of multiple experimental treatments by testing against the same control.

Autor: Chiarappa JA; Merck and Co. Inc., North Wales, PA, USA., Hoover DR; Department of Statistics and the Institute for Health, Health Care Policy and Aging Research, Rutgers University, Piscataway, NJ, USA., Pedley A; Merck and Co. Inc., North Wales, PA, USA.

Publikováno v: Statistical methods in medical research [Stat Methods Med Res] 2023 Aug; Vol. 32 (8), pp. 1604-1615. Date of Electronic Publication: 2023 Jun 29.

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH).

Autor: Song JY; Korea University College of Medicine, Seoul, South Korea., Chang CJ; National Cheng Kung University, Tainan, Taiwan., Andrews C; Diagnostics Research Group, San Antonio, TX, USA., Diez-Domingo J; FISABIO, Valencia, Spain., Oh MD; Seoul National University College of Medicine, Seoul, South Korea., Dagan R; Ben-Gurion University, Beer-Sheva, Israel., Hartzel J; Merck & Co., Inc., Kenilworth, NJ, USA., Pedley A; Merck & Co., Inc., Kenilworth, NJ, USA., Li J; Merck & Co., Inc., Kenilworth, NJ, USA., Sterling T; Merck & Co., Inc., Kenilworth, NJ, USA., Tamms G; Merck & Co., Inc., Kenilworth, NJ, USA., Chiarappa JA; Merck & Co., Inc., Kenilworth, NJ, USA., Lutkiewicz J; Merck & Co., Inc., Kenilworth, NJ, USA., Musey L; Merck & Co., Inc., Kenilworth, NJ, USA., Tu Y; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: ying.mei.tu@merck.com., Buchwald UK; Merck & Co., Inc., Kenilworth, NJ, USA. Electronic address: ubuchwa1@jhmi.edu.

Publikováno v: Vaccine [Vaccine] 2021 Oct 15; Vol. 39 (43), pp. 6422-6436. Date of Electronic Publication: 2021 Sep 04.

PGI34 - Systematic Literature Review of Real-World Evidence on Adherence with Biologics in Inflammatory Bowel Disease in the United States

Autor: Rupniewska, E, Singer, D, Khan, S, Neighbors, M, Chiarappa, JA, Obando, CA

Publikováno v: In Value in Health May 2018 21 Supplement 1:S87-S87

Clinical outcomes associated with pathogenic genomic instability mutations in prostate cancer: a retrospective analysis of US pharmacy and medical claims data.

Autor: Liu J; Janssen Scientific Affairs, LLC , Horsham , PA , USA., Near A; IQVIA , Falls Church , VA , USA., Chiarappa JA; Janssen Scientific Affairs, LLC , Horsham , PA , USA., Wada K; IQVIA , Falls Church , VA , USA., Tse J; IQVIA , Falls Church , VA , USA., Burudpakdee C; IQVIA , Falls Church , VA , USA., Behl A; Janssen Scientific Affairs, LLC , Horsham , PA , USA., Ranganath R; Janssen Medical Affairs, LLC , Horsham , PA , USA., Antonarakis ES; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore , MD , USA.

Publikováno v: Journal of medical economics [J Med Econ] 2019 Oct; Vol. 22 (10), pp. 1080-1087. Date of Electronic Publication: 2019 Aug 28.

Germline Mutations in Patients With Early-Onset Prostate Cancer.

Autor: Tang, Tang, Tan, Xintao, Wang, Ze, Wang, Shuo, Wang, Yapeng, Xu, Jing, Wei, Xiajie, Zhang, Dianzheng, Liu, Qiuli, Jiang, Jun

Publikováno v: Frontiers in Oncology; 6/6/2022, Vol. 12, p1-9, 9p